These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25803882)

  • 41. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment.
    O'Brien JT; Desmond P; Ames D; Schweitzer I; Chiu E; Tress B
    Psychol Med; 1997 Nov; 27(6):1267-75. PubMed ID: 9403898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid/serum IgG index is correlated with medial temporal lobe atrophy in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2008; 25(2):144-7. PubMed ID: 18097142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of emotionally-rated material on visual memory in Alzheimer's disease in relation to medial temporal atrophy.
    Landré L; Sava AA; Krainik A; Lamalle L; Krolak-Salmon P; Chainay H
    J Alzheimers Dis; 2013; 36(3):535-44. PubMed ID: 23635407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Impact of combined medial temporal atrophy and white matter lesions on the cognitive and emotional functions in Alzheimer's disease patients].
    Tokuchi R; Deguchi K; Yamashita T; Abe K
    Nihon Ronen Igakkai Zasshi; 2014; 51(4):342-9. PubMed ID: 25327368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
    J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer's disease.
    Son JH; Han DH; Min KJ; Kee BS
    Neurosci Lett; 2013 Aug; 548():15-20. PubMed ID: 23727389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease.
    Bruen PD; McGeown WJ; Shanks MF; Venneri A
    Brain; 2008 Sep; 131(Pt 9):2455-63. PubMed ID: 18669506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions.
    Fischer CE; Ting WK; Millikin CP; Ismail Z; Schweizer TA;
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):76-82. PubMed ID: 25821062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between depressive symptoms and prefrontal hypoperfusion demonstrated by eZIS in patients with DAT.
    Akiyama H; Hashimoto H; Kawabe J; Higashiyama S; Kai T; Kataoka K; Shimada A; Inoue K; Shiomi S; Kiriike N
    Neurosci Lett; 2008 Aug; 441(3):328-31. PubMed ID: 18590798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between finger movement characteristics and brain voxel-based morphometry.
    Sugioka J; Suzumura S; Kuno K; Kizuka S; Sakurai H; Kanada Y; Mizuguchi T; Kondo I
    PLoS One; 2022; 17(10):e0269351. PubMed ID: 36206254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease.
    Erkinjuntti T; Lee DH; Gao F; Steenhuis R; Eliasziw M; Fry R; Merskey H; Hachinski VC
    Arch Neurol; 1993 Mar; 50(3):305-10. PubMed ID: 8442711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.
    de Leeuw FE; Korf E; Barkhof F; Scheltens P
    Stroke; 2006 Sep; 37(9):2248-52. PubMed ID: 16902173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.
    Convit A; De Leon MJ; Tarshish C; De Santi S; Tsui W; Rusinek H; George A
    Neurobiol Aging; 1997; 18(2):131-8. PubMed ID: 9258889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nurturing syndrome: a form of pathological bereavement with delusions in Alzheimer's disease.
    Venneri A; Shanks MF; Staff RT; Della Sala S
    Neuropsychologia; 2000; 38(2):213-24. PubMed ID: 10660231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship between atrophy of the medial temporal area and daily activities in older adults with mild cognitive impairment.
    Yoshida D; Shimada H; Makizako H; Doi T; Ito K; Kato T; Shimokata H; Washimi Y; Endo H; Suzuki T
    Aging Clin Exp Res; 2012 Oct; 24(5):423-9. PubMed ID: 22395286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type.
    DeCarli C; Murphy DG; McIntosh AR; Teichberg D; Schapiro MB; Horwitz B
    Psychiatry Res; 1995 Jul; 57(2):119-30. PubMed ID: 7480379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.